Standard BioTools (LAB) Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. SPY
7. INTC
8. JBLU
9. AAPL
10. NVDA

Go back to Standard BioTools (LAB) Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

January 9, 2023 8:30 AM EST

Continued commercial and strategic execution delivers sequential core revenue growth of 4%9% to $26 million$27 million in Q4 2022 for full year total of approximately $94 million$95 million

Business restructuring and SBS program on track to deliver over 20% reduction in operating expenses or more than $30 million and reduces annual operating expenses to approximately $100 million exiting Q4. GAAP operating expense reductions are expected to be over 25% and over $35 million.

On track for achieving stated goal of 65%68% non-GAAP gross margins by the end of 2023. GAAP... More